Sort
10,766 grants matching “checkpoint inhibitor”
Identifying Effective Immune Checkpoint Therapy Strategies in Triple Negative Breast Cancer
$59,038Daniel Patrick Hollern · Univ Of North Carolina Chapel Hill · F32 · FY2018 · CA
Mechanisms of Response and Resistance to Immune Checkpoint Inhibitors in Lung Adenocarcinoma
$59,038Katherine Renee Amato Hastings · Yale University · F32 · FY2018 · CA
Targeting Epithelial-Immune Cell Crosstalk to Improve Therapy in Pancreatic Cancer
$59,038Christopher J. Halbrook · University Of Michigan At Ann Arbor · F32 · FY2018 · CA
Defining immune footprint in tumor microenvironment following high salt synergized inflammatory cytokine mediated breast cancer progression
$59,032Jens Marc Titze · Vanderbilt University Medical Center · U54 · FY2018 · CA
Defining immune footprint in tumor microenvironment following high salt synergized inflammatory cytokine mediated breast cancer progression
$59,032Jens Marc Titze · Vanderbilt University Medical Center · U54 · FY2016 · CA
Defining immune footprint in tumor microenvironment following high salt synergized inflammatory cytokine mediated breast cancer progression
$59,032Jens Marc Titze · Vanderbilt University Medical Center · U54 · FY2017 · CA
Role of type 2 immune response in pancreatic cancer tumorigenesis
$58,959Prasenjit Dey · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA
INTERACTION OF YEAST CHECKPOINT PROTEINS AS DRUG ASSAY
$58,877Emory University · R01 · FY2002 · CA
Clinical Research Program
$58,533Matthew I Milowsky · Univ Of North Carolina Chapel Hill · P30 · FY2024 · CA
Targeting Epithelial-Immune Cell Crosstalk to Improve Therapy in Pancreatic Cancer
$58,338Christopher J. Halbrook · University Of Michigan At Ann Arbor · F32 · FY2019 · CA
Signal Transduction Research Program
$58,258Daniel Peter Petrylak · Yale University · P30 · FY2018 · CA
Signal Transduction Research Program
$58,258Daniel Peter Petrylak · Yale University · P30 · FY2019 · CA
Signal Transduction Research Program
$58,258Daniel Peter Petrylak · Yale University · P30 · FY2022 · CA
Signal Transduction Research Program
$58,258Daniel Peter Petrylak · Yale University · P30 · FY2020 · CA
Signal Transduction Research Program
$58,258Daniel Peter Petrylak · Yale University · P30 · FY2021 · CA
Cancer Immunology Research Program
$58,257Lieping Chen · Yale University · P30 · FY2018 · CA
Cancer Immunology Research Program
$58,257Lieping Chen · Yale University · P30 · FY2019 · CA
Cancer Immunology Research Program
$58,257Lieping Chen · Yale University · P30 · FY2021 · CA
Cancer Immunology Research Program
$58,257Marcus W Bosenberg · Yale University · P30 · FY2022 · CA
Cancer Immunology Research Program
$58,257Lieping Chen · Yale University · P30 · FY2020 · CA
Investigating concurrent Ras-pathway inhibition to optimize response to anti-PD-1 therapy in NRAS-mutant melanoma
$58,200Caroline Nebhan · Vanderbilt University Medical Center · F32 · FY2021 · CA
(Diversity supplement to R01CA188096) Targeting autophagaphy in hereditary breast cancer
$57,707Bing Xia · Rbhs -Cancer Institute Of New Jersey · R01 · FY2017 · CA
T cell expressed miR-155 promotes antitumor immunity and immune checkpoint blockade responses in colon cancer through repression of Ship1
$57,538William Weihao Tang · Utah State Higher Education System--University Of Utah · F30 · FY2025 · CA
Molecular engineering and systematic evaluation of bispecific aptamers to develop potent and efficacious therapies for the immunomodulation of Non-Small Cell Lung Cancer
$57,538Brian J Thomas · University Of Missouri-Columbia · F30 · FY2025 · CA
Immunoediting in Cutaneous Squamous Cell Carcinoma
$57,538Elizabeth Borden · University Of Arizona · F30 · FY2025 · CA